Literature DB >> 25544360

Tanshinone IIA therapeutically reduces LPS-induced acute lung injury by inhibiting inflammation and apoptosis in mice.

Min Xu1, Fa-le Cao2, Yu-fei Zhang3, Liang Shan4, Xiao-ling Jiang1, Xiao-jing An3, Wei Xu1, Xiu-zhi Liu1, Xiao-yan Wang1.   

Abstract

AIM: To study the effects of tanshinone IIA (TIIA) on lipopolysaccharide (LPS)-induced acute lung injury in mice and the underlying mechanisms.
METHODS: Mice were injected with LPS (10 mg/kg, i.p.), then treated with TIIA (10 mg/kg, i.p.). Seven hours after LPS injection, the lungs were collected for histological study. Protein, LDH, TNF-α and IL-1β levels in bronchoalveolar lavage fluid (BALF) and myeloperoxidase (MPO) activity in lungs were measured. Cell apoptosis and Bcl-2, caspase-3, NF-κB and HIF-1α expression in lungs were assayed.
RESULTS: LPS caused marked histological changes in lungs, accompanied by significantly increased lung W/D ratio, protein content and LDH level in BALF, and Evans blue leakage. LPS markedly increased neutrophil infiltration in lungs and inflammatory cytokines in BALF. Furthermore, LPS induced cell apoptosis in lungs, as evidenced by increased TUNEL-positive cells, decreased Bcl-2 content and increased cleaved caspase-3 content. Moreover, LPS significantly increased the expression of NF-κB and HIF-1α in lungs. Treatment of LPS-injected mice with TIIA significantly alleviated these pathological changes in lungs.
CONCLUSION: TIIA alleviates LPS-induced acute lung injury in mice by suppressing inflammatory responses and apoptosis, which is mediated via inhibition of the NF-κB and HIF-1α pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544360      PMCID: PMC4326786          DOI: 10.1038/aps.2014.112

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  48 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

2.  Protection from lethal apoptosis in lipopolysaccharide-induced acute lung injury in mice by a caspase inhibitor.

Authors:  M Kawasaki; K Kuwano; N Hagimoto; T Matsuba; R Kunitake; T Tanaka; T Maeyama; N Hara
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits.

Authors:  G Matute-Bello; W C Liles; C W Frevert; M Nakamura; K Ballman; C Vathanaprida; P A Kiener; T R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-08       Impact factor: 5.464

Review 4.  Epidemiology of sepsis: an update.

Authors:  D C Angus; R S Wax
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

5.  Relationship between inflammatory cells in bronchoalveolar lavage fluid and pathologic changes in the lung interstitium.

Authors:  C Yoshii; N Nagata; Y Tao; R Suematsu; Y Nikaido; M Kido
Journal:  Respiration       Date:  1998       Impact factor: 3.580

6.  Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice.

Authors:  Y Kitamura; S Hashimoto; N Mizuta; A Kobayashi; K Kooguchi; I Fujiwara; H Nakajima
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

7.  Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide, and pressure support ventilation.

Authors:  Z H Zhou; B Sun; K Lin; L W Zhu
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

8.  Characterization of a murine model of endotoxin-induced acute lung injury.

Authors:  Koroush Kabir; Jean-Pierre Gelinas; Meihong Chen; Dongfen Chen; Dexin Zhang; Xiaoxing Luo; Jing-Hua Yang; Darryl Carter; Reuven Rabinovici
Journal:  Shock       Date:  2002-04       Impact factor: 3.454

9.  Acute lung injury by sepsis and acid aspiration: a key role for cytosolic phospholipase A2.

Authors:  T Nagase; N Uozumi; S Ishii; K Kume; T Izumi; Y Ouchi; T Shimizu
Journal:  Nat Immunol       Date:  2000-07       Impact factor: 25.606

10.  Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats.

Authors:  Y Tesfaigzi; M J Fischer; A J Martin; J Seagrave
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

View more
  19 in total

1.  Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway.

Authors:  Hongyi Hu; Dongsheng Shi; Chenlu Hu; Xiao Yuan; Juan Zhang; Huaqin Sun
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Circulating and tissue biomarkers as predictors of bromine gas inhalation.

Authors:  Juan Xavier Masjoan Juncos; Shazia Shakil; Aamir Ahmad; Duha Aishah; Charity J Morgan; Louis J Dell'Italia; David A Ford; Aftab Ahmad; Shama Ahmad
Journal:  Ann N Y Acad Sci       Date:  2020-07-09       Impact factor: 5.691

3.  Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities.

Authors:  S Zhang; G Huang; K Yuan; Q Zhu; H Sheng; R Yu; G Luo; A Xu
Journal:  Clin Exp Immunol       Date:  2017-07-03       Impact factor: 4.330

Review 4.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

5.  Anti-Inflammatory Activity of Tanshinone IIA in LPS-Stimulated RAW264.7 Macrophages via miRNAs and TLR4-NF-κB Pathway.

Authors:  Guanwei Fan; Xiaorui Jiang; Xiaoyan Wu; Patrick Asare Fordjour; Lin Miao; Han Zhang; Yan Zhu; Xiumei Gao
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  Tanshinone IIA improves diabetes mellitus via the NF-κB-induced AMPK signal pathway.

Authors:  Feng-Yi Yuan; Min Zhang; Ping Xu; Dan Xu; Ping Chen; Min Ren; Qin Sun; Jing-Yan Chen; Juan Du; Xia-Lian Tang
Journal:  Exp Ther Med       Date:  2018-09-03       Impact factor: 2.447

7.  Protective effects of hesperetin on lipopolysaccharide-induced acute lung injury in a rat model.

Authors:  Serkan Kaya; Sinem Albayrak Kaya; Elif Polat; Zeynep Fidanol Erboğa; Yasin Duran; Fatin Rüştü Polat; Hamza Malik Okuyan; İhsan Karaboğa
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

8.  The anti-inflammatory activities of ethanol extract from Dan-Lou prescription in vivo and in vitro.

Authors:  Li-Na Gao; Xin Zhou; Yi Zhang; Yuan-Lu Cui; Chun-Quan Yu; Shan Gao
Journal:  BMC Complement Altern Med       Date:  2015-09-09       Impact factor: 3.659

9.  Bufexamac ameliorates LPS-induced acute lung injury in mice by targeting LTA4H.

Authors:  Qiang Xiao; Ningning Dong; Xue Yao; Dang Wu; Yanli Lu; Fei Mao; Jin Zhu; Jian Li; Jin Huang; Aifang Chen; Lu Huang; Xuehai Wang; Guangxiao Yang; Guangyuan He; Yong Xu; Weiqiang Lu
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

10.  Tanshinones and diethyl blechnics with anti-inflammatory and anti-cancer activities from Salvia miltiorrhiza Bunge (Danshen).

Authors:  Hongwei Gao; Wen Sun; Jianping Zhao; Xiaxia Wu; Jin-Jian Lu; Xiuping Chen; Qiong-Ming Xu; Ikhlas A Khan; Shilin Yang
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.